2m 2m 2m 2m 2m 2m 2m
GT BIOPHARMA (GTBP)
NASDAQ
$0.29-$0.002 (-0.51%)
Price as of Aug 03, 2026 9:00 AM EDT- $10.6MMarket Cap
- -83.78%1-Year Change
- BiotechnologyIndustry
GT BIOPHARMA (GTBP)
$0.29-$0.002 (-0.51%)
GTBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.29 | ||
Change | -$0.01 (-4.65%) | ||
Open | $0.31 | ||
High | $0.31 | ||
Low | $0.28 | ||
Previous Close | $0.31 | ||
Volume | 602,176 | ||
30-Day Average Volume | 806,405 | ||
1-Week Change | -9.50% | ||
1-Month Change | -40.07% | ||
1-Year Change | -83.78% | ||
3-Year Change | -96.44% | ||
5-Year Change | -99.90% | ||
Fundamentals | |||
Shares Outstanding | 36.1M | ||
Total Assets | $10.0M | ||
Market Cap | $10.6M | ||
Enterprise Value | $1.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$3.4M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $7.6M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/05/2024 | ||
Earnings & Revenue